Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement

J. Wesson Ashford, Frederick A. Schmitt, Michael F. Bergeron, Peter J. Bayley, James O. Clifford, Qun Xu, Xiaolei Liu, Xianbo Zhou, Vinod Kumar, Herman Buschke, Margaret Dean, Sanford I. Finkel, Lee Hyer, George Perry

Research output: Contribution to journalArticlepeer-review

Abstract

Wang et al. analyze Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment accuracy as screening tests for detecting dementia associated with Alzheimer's disease (AD). Such tests are at the center of controversy regarding recognition and treatment of AD. The continued widespread use of tools such as MMSE (1975) underscores the failure of advancing cognitive screening and assessment, which has hampered the development and evaluation of AD treatments. It is time to employ readily available, efficient computerized measures for population/mass screening, clinical assessment of dementia progression, and accurate determination of approaches for prevention and treatment of AD and related conditions.

Original languageEnglish (US)
Pages (from-to)305-315
Number of pages11
JournalJournal of Alzheimer's disease : JAD
Volume87
Issue number1
DOIs
StatePublished - 2022

Keywords

  • Alzheimer’s disease
  • cognition assessment
  • computerized testing
  • MemTrax
  • Mini-Mental State Examination
  • Montreal Cognitive Assessment
  • neuroplasticity

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement'. Together they form a unique fingerprint.

Cite this